Anavex Life Sciences Corp (AVXL)

[Investor2014]

I gather Missling filed for both Rett and PD around Oct 19th and the next week the FDA axed the PD trial and thus the surprise move of PD to EU. It is a surprise moving to EU. No way was that planned when Missling said 3 trials to starting 2017. If PD was to go the EU route from day 1, the EU submission would have been done already. Now we learn in won't be until Q1 2018. Surely someone at HQ missed diagnosis the FDA allowing both Rett and PD to start concurrently.

I suspect you are reading far to much into lack of information. To me it is much more likely that Europe has been chosen since the pre-clinical work and expertise in Parkinson's has come from Lund University in Sweden.